Jul 24, 2018
New Healios® Supplement From Enlivity Offers Relief for Oral Mucositis
Jul 19, 2018
Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
Jun 04, 2018
Soligenix Announces Poster at the 2018 American Society of Microbiology Microbe Conference in Atlanta, Georgia
May 11, 2018
Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results
May 07, 2018
Soligenix to Present at the NYC Oncology Investor Conference 2018
May 02, 2018
U.S. Patent Granted for BUPI
Apr 24, 2018
Enzychem Lifesciences' Fast Track Designation for chemo-radiation induced oral mucositis had been granted by the FDA
Mar 15, 2018
Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
Mar 13, 2018
Soligenix to Present at the 12th Annual International Partnering Conference Bio-Europe Spring
Jan 25, 2018
Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
Jan 02, 2018
Soligenix Announces US Patent Issuance for Use of Dusquetide in Oral Mucositis
Nov 27, 2017
Soligenix Announces Presentation and Poster at the 2017 Chemical and Biological Defense Science and Technology Conference in Long Beach, CA
Nov 13, 2017
Soligenix to Present at the 2017 Biotech and Money Showcase Conference
Nov 09, 2017
Soligenix to Present Data on Dusquetide in Combating Antibiotic-Resistant Infections at the 2nd Annual Superbugs & Superdrugs USA Conference
Oct 24, 2017
Broad-Spectrum Innate Defense Regulator Platform Technology to be Presented at the Peptide Therapeutics Foundation Symposium
Oct 17, 2017
Soligenix to Present at the 3rd Annual Dawson James Small Cap Conference
Oct 05, 2017
Dusquetide Technology Platform to be Presented at the 2nd World Congress and Expo on Immunology
Sep 20, 2017
Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
Sep 11, 2017
Dusquetide as a Potential Solution to Antimicrobial Resistant Bacteria to be Presented at the 2017 World Anti-Microbial Resistance Congress
Sep 07, 2017
Soligenix to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York City